StonvexLoading…
StonvexStonvexStonvexCore line items from ELA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 | Q3 2023 2023-09-30 | Q2 2023 2023-06-30 |
|---|---|---|---|---|
Revenue | $39.86M | $171.67M | $134.96M | $98.69M |
Operating Income | $2.34M | $8.76M | $7.16M | $5.21M |
Net Income | $1.91M | $7.15M | $5.84M | $4.13M |
EPS (Diluted) | $0.07 | $0.27 | $0.22 | $0.15 |
Total Assets | $74.75M | $73.47M | $74.20M | $73.61M |
Total Liabilities | $25.43M | $25.17M | $26.36M | $26.35M |
Cash & Equivalents | $19.78M | $17.85M | $17.31M | $18.38M |
Free Cash Flow OCF − CapEx | $3.34M | $3.80M | $1.91M | $1.45M |
Shares Outstanding | 26.51M | 26.51M | 26.70M | 26.90M |